Filing Details

Accession Number:
0001131399-10-000006
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-30 12:13:21
Reporting Period:
2010-11-29
Filing Date:
2010-11-30
Accepted Time:
2010-11-30 12:13:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1080014 Theravance Inc THRX Pharmaceutical Preparations (2834) 943265960
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1131399 Plc Glaxosmithkline 980 Great West Road
Brentford Middlesex X0 TW8 9GS
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-11-29 5,750,000 $22.50 5,750,000 No 4 P Indirect by Corporation
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect by Corporation
Footnotes
  1. The amount of Common Stock reported as beneficially owned by the Reporting Person following the reported transaction does not include the Reporting Person's previously disclosed beneficial ownership of 9,401,499 shares of Class A Common Stock of Theravance,Inc. (the "Class A Common Stock"), which are held of record by GlaxoSmithKline LLC and Glaxo Group Limited ("GGL"), each of which is a wholly-owned subsidiary of the Reporting Person. Each share of Class A Common Stock may be converted into one share of Common Stock at any time.
  2. Shares of Common Stock are held of record by GGL.